^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Poly-ICLC matured DC adjuvanted NY-ESO-1/Melan-A-MART-1 peptide vaccine

    i
    Other names: Poly-ICLC matured DC adjuvanted NY-ESO-1/Melan-A-MART-1 peptide vaccine
    Associations

    News

    Trials
    Company:
    Icahn School of Medicine at Mount Sinai
    Drug class:
    Immunostimulant
    Related drugs:
    Associations

    News

    Trials
    2years
    A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence (clinicaltrials.gov)
    P2, N=36, Completed, Nina Bhardwaj | Active, not recruiting --> Completed
    Trial completion
    |
    CD8 (cluster of differentiation 8) • CTAG1B (Cancer/testis antigen 1B) • CD4 (CD4 Molecule)
    |
    Hiltonol (poly-ICLC) • Poly-ICLC matured DC adjuvanted NY-ESO-1/Melan-A-MART-1 peptide vaccine